With individualized programs in the offering, we offer a fast-track early-stage development service for your ADC and bioconjugate program to meet your needs.
Piramal Pharma Solutions offers ADC proof of concept service to demonstrate the viability of cytotoxic drugs or monoclonal antibodies to be used as therapeutic ADCs